Baiqu Bio completed nearly 100 million yuan in Series A financing

Baiqu Bio is a high-tech enterprise specializing in the application, consultation and development of cutting-edge research technologies in life sciences. It is also an early detection and analysis service organization engaged in comprehensive metabolomics solutions in China. Recently, Baiqu Bio has completed a round of financing of nearly 100 million yuan. This round of financing was exclusively led by Qiming Venture Partners.

This article is reproduced from: https://www.itjuzi.com/investevent/13350455
This site is for inclusion only, and the copyright belongs to the original author.

Leave a Comment